INSM Insmed Inc

USD 27.13 -0.19 -0.695461
Icon

Insmed Inc (INSM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 27.13

-0.19 (-0.70)%

USD 3.92B

1.13M

USD 46.83(+72.63%)

USD 0.00 (-100.00%)

Icon

INSM

Insmed Inc (USD)
COMMON STOCK | NSD
USD 27.13
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.92B

USD 0.00 (-100.00%)

USD 27.13

Insmed Inc (INSM) Stock Forecast

Show ratings and price targets of :
USD 46.83
(+72.63%)

Based on the Insmed Inc stock forecast from 5 analysts, the average analyst target price for Insmed Inc is USD 46.83 over the next 12 months. Insmed Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Insmed Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Insmed Inc’s stock price was USD 27.13. Insmed Inc’s stock price has changed by +3.00% over the past week, -3.21% over the past month and +61.49% over the last year.

No recent analyst target price found for Insmed Inc
No recent average analyst rating found for Insmed Inc

Company Overview Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease ...Read More

https://www.insmed.com

700 US Highway 202/206, Bridgewater, NJ, United States, 08807

912

December

USD

USA

Adjusted Closing Price for Insmed Inc (INSM)

Loading...

Unadjusted Closing Price for Insmed Inc (INSM)

Loading...

Share Trading Volume for Insmed Inc Shares

Loading...

Compare Performance of Insmed Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for INSM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Insmed Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing INSM

Symbol Name INSM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Insmed Inc (INSM) Stock

Based on ratings from 5 analysts Insmed Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 6 buy, sell and hold ratings.

Unfortunately we do not have enough data on INSM's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for INSM is USD 46.83 over the next 12 months. The maximum analyst target price is USD 55 while the minimum anlayst target price is USD 36.

Unfortunately we do not have enough data on INSM's stock to indicate if its overvalued.

The last closing price of INSM's stock was USD 27.13.

The most recent market capitalization for INSM is USD 3.92B.

Based on targets from 5 analysts, the average taret price for INSM is projected at USD 46.83 over the next 12 months. This means that INSM's stock price may go up by +72.63% over the next 12 months.

We can't find any ETFs which contains Insmed Inc's stock.

As per our most recent records Insmed Inc has 912 Employees.

Insmed Inc's registered address is 700 US Highway 202/206, Bridgewater, NJ, United States, 08807. You can get more information about it from Insmed Inc's website at https://www.insmed.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...